GDRX vs TDOC
GDRX: GoodRx is a leading digital healthcare platform that provides price transparency and discount tools to help Americans save money on prescription medications and access healthcare services. TDOC: A global leader in virtual care services, connecting patients to providers for a wide range of medical, specialty, and chronic condition management needs.
Side-by-side fundamentals
| Metric | GDRX | TDOC | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $3.07 | $6.71 | |
| Market cap as of 2026-08-03 | $1.0B | $1.2B | |
| P/E as of 2026-08-03 | 52.57 | n/a | |
| PEG as of 2026-08-03 | -47.17 | n/a | |
| Net margin as of 2026-08-03 | +2.6% | -7.1% | GDRX higher |
| Gross margin as of 2026-08-03 | +91.8% | +69.0% | GDRX higher |
| Operating margin as of 2026-08-03 | +9.9% | -7.5% | GDRX higher |
| ROE as of 2026-08-03 | +3.3% | -13.1% | GDRX higher |
| ROA as of 2026-08-03 | +1.4% | -6.3% | GDRX higher |
| Debt / equity as of 2026-08-03 | 0.78 | 0.76 | TDOC lower |
| Revenue growth (YoY) as of 2026-08-03 | -1.2% | -2.1% | GDRX higher |
| Revenue CAGR (3y) SEC XBRL | +1.3% | +1.7% | TDOC higher |
| Beta as of 2026-08-03 | 1.13 | 1.35 | |
| 1-year return as of 2026-07-31 close | -35.9% | -6.9% | TDOC higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.